The U.S. Food and Drug Administration (FDA) has approved a new opioid painkiller called Onsolis for patients with severe cancer-related pain. According to FDA officials, Onsolis delivers the narcotic fentanyl through an absorbable film that sticks to the inside of the patient's cheek. Onsolis is only cleared for use adult cancer patients who already use opioid pain medications around the clock and who need additional pain relief. The FDA has built in several safeguard measures to ensure that...
Read moreRecently, we have discussed articles in the scientific literature that have raised concerns that prescription pain medications are at times... Read more »
Neck pain in the morning can be due to straining the neck while asleep. During certain stages of sleep, the muscles are contracted. One... Read more »
Full Question: I'm 47 years old, and for the last two years, my migraines have become progressively more painful. The worst aspect of... Read more »
The Food and Drug Administration has approved the opioid drug Fentora (fentanyl buccal) for the treatment of breakthrough pain in people with cancer.... Read more »
Research published in the medical journal Pain has found that though the different varieties of facial pain conditions can cause debilitating... Read more »
Results from a new survey suggest that 75 percent of adult cancer patients experience severe flares of breakthrough pain, and these can affect the... Read more »
The U.S. Food and Drug Administration (FDA) has granted 'Fast Track' designation to a new painkiller made by drugmaker Collegium Pharmaceuticals, the... Read more »
A reader asks Dr. Paul Donohue about the appropriateness of a severe-pain patient's use of addictive painkillers. The reader's mother has terminal... Read more »